Executive Summary
Stem Cell Sciences plc is a global biotechnology company focused on the development of stem cell technologies. The Company has established a leading intellectual property (IP) and technology portfolio that enables the commercial application of stem cells in pharmaceutical and biotechnology drug discovery, providing the Company with an early-stage revenue stream. In the longer term, the Company is developing regenerative, cell-based therapies. Stem Cell Sciences has four business units focused on key sustainable business strategies. SC Proven provides serum free, cell culture media and reagents that enable the growth of stem cells. The first commercially available product, a mouse embryonic stem cell growth medium, has been exclusively licensed for manufacture and marketing to Chemicon, a division of Serologicals Inc. SC Licensing licenses its proprietary technologies such as Internal Ribosome Entry Site (IRES) and Stem Cell Selection for application in laboratory-based research and discovery. SC Services will provide cell production for research and high-throughput drug screening. SC Therapies first program is being undertaken by SCS's Japanese affiliate, which recently announced the exclusive licensing of human multipotent adipocyte-derived (hMads) for use in an experimental cell based therapy programme against Duchene's Muscular Dystrophy form the basis for a degenerative diseases focused pre-clincial programme. SCS plc is a global Group with operations in the UK, Australia and Japan. Each company is affiliated with academic stem cell centers of excellence in order to access and commercialize new IP developing in the field. These include the Institute of Stem Cell Research, Edinburgh, UK; RIKEN Centre for Development Biology, Japan and the Australian Stem Cell Centre, Melbourne, Australia.
Company History
Current Events
Business Model
Products/Services
Segments/Customers
Production/Operations
Distribution/Routes to Market
Market & Competition
Market Share
Main Competitors
Competitive Strengths and Weaknesses
Management
Financials
Profit & Loss
Balance sheet
Cashflow
Valuation
Comparable Companies
SWOT Analysis
Strengths
Weaknesses
Opportunities
Threats
